The irreversible binding of amyloid peptide substrates to insulin-degrading enzyme A biological perspective
The irreversible binding of amyloid peptide substrates to insulin-degrading enzyme A biological perspective
复制标题
DOI:
10.4161/pri.2.2.6710
复制
发表时间:
2008-04-01
期刊:
影响因子:
2.3
通讯作者:
Castano, Eduardo M.
中科院分区:
文献类型:
--
作者:
de Tullio, Matias B.;Morelli, Laura;Castano, Eduardo M.
Insulin-degrading enzyme (IDE) is a conserved Zn2+ metalloendopeptidase involved in insulin degradation and in the maintenance of brain steady-state levels of amyloid beta peptide (A beta) of Alzheimer's disease (AD). Our recent demonstration that IDE and A beta are capable of forming a stoichiometric and extremely stable complex raises several intriguing possibilities regarding the role of this unique protein-peptide interaction in physiological and pathological conditions. These include a protective cellular function of IDE as a "dead-end chaperone" alternative to its proteolytic activity and the potential impact of the irreversible binding of A beta to IDE upon its role as a varicella zoster virus receptor. In a pathological context, the implications for insulin signaling and its relationship to AD pathogenesis are discussed. Moreover, our findings warrant further research regarding a possible general and novel interaction between amyloidogenic peptides and other Zn2+ metallopeptidases with an IDE-like fold and a substrate conformation-dependent recognition mechanism.